Kilroy Realty Corporation – Consensus ‘Buy’ rating and 24.9% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Kilroy Realty Corporation which can be found using ticker (KRC) now have 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The target price High/Low ranges between 48 and 31 calculating the mean target price we have $39.77. Given that the stocks previous close was at $31.84 this would imply there is now a potential upside of 24.9%. The 50 day MA is $34.77 and the 200 moving average now moves to $42.59. The total market capitalization for the company now stands at $3,574m. Visit the company website at: https://www.kilroyrealty.com

The potential market cap would be $4,465m based on the market consensus.

Kilroy Realty Corporation (NYSE: KRC, the “company”, “KRC”) is a leading West Coast landlord and developer, with a major presence in San Diego, Greater Los Angeles, the San Francisco Bay Area, and the Pacific Northwest. The company has earned global recognition for sustainability, building operations, innovation and design. As pioneers and innovators in the creation of a more sustainable real estate industry, the company’s approach to modern business environments helps drive creativity, productivity and employee retention for some of the world’s leading technology, entertainment, life science and business services companies. KRC is a publicly traded real estate investment trust (“REIT”) and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring and managing office and mixed-use projects. As of September 30, 2020, KRC’s stabilized portfolio totaled approximately 14.3 million square feet of primarily office and life science space that was 92.2% occupied and 95.5% leased. The company also had 808 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 85.0% and 37.5%, respectively. In addition, KRC had seven in-process development projects with an estimated total investment of $1.9 billion, totaling approximately 2.3 million square feet of office and life science space. The office and life science space was 90% leased.

The company has a dividend yield of 6.78% with the ex dividend date set at 30-3-2023 (DMY).

Other points of data to note are a P/E ratio of 15.35, revenue per share of 9.39 and a 1.9% return on assets.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search